Position in ZTS
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$7,042
-$5,133 QoQ
Shares Held
98
-4.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,269
of 1,408 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Derivatives in ZTS
reported options exposure · as of Mar 31, 2025CallValue
$0
CallShares
0
PutValue
$17,123
PutShares
104
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Quaker Wealth Management, LLC holds $35,373 across 11 Drug Manufacturers - Specialty & Generic names. ZTS ranks #2 (19.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
1,592 | $14,853 | |
| 2 | ZTS |
Zoetis Inc.
This page
|
98 | $7,042 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
200 | $6,934 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
7 | $3,792 | |
| 5 | VTRS |
Viatris Inc
|
75 | $1,191 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
30 | $738 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
4 | $674 | |
| 8 | CGC |
Canopy Growth Corp
|
100 | $95 |
All Filings in ZTS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,042 | 98 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $12,175 | 103 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $12,582 | 100 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $15,217 | 104 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $15,283 | 98 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $17,123 | 104 | Put | Sole | 2025-05-29 | |
| No filing history on record for this holder in this stock. | ||||||